Skip to content

Dr. Goedele Malfroid

Active
Private limited companyfounded 2006active for 19 yearsKerkhofweg 8, 2430 Laakdal, BelgiumKBO/BCE: BE 0885.242.784

From the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Goedele Malfroid has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €619,104 and a net result of €96,431. Equity has been growing by about 5.1% per year since 2018. Its solvency ranks better than 95% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 27-11-2006 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.302.461.977 2440 Geel, since 27-11-2006
Financial year end
31 December
Peppol
Reachable since 19-12-2025

Board and ownership

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€182,352
▲ 16.8%
Turnover
≈ €340,000
estimated
Profit
€96,431
▲ 57.4%
Equity
€619,104
▲ 10.4%
Total assets
€633,425
=
Filed on 23-07-2026, 8 days before the deadlineat the National Bank
Score breakdownraises riskLiquidity: current ratio 21.86, cash €11,572, halvedlowers riskSector: Human health activities (NACE 86)Size: total assets €633,425Figures for financial year 2025 (filed on 23-07-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 97.7% of total assets
Liquidity 52-2
short-term debt 2.3% · cash 1.8%
Profitability 88+7
return on assets 15.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 21.86 (3.71 in 2024), above the usual 1.5. Short-term debt is 2.3% and cash 1.8% of total assets. 2.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 26% on liquidity, 41% on profitability and 53% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 21.86, cash €11,572, halved
NBB · annual accounts
lowers risk · Size: total assets €633,425
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 23-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
8 days early
2024
7 days early
2023
8 days early
2022
on the day
2021
5 days early
2020
25 days early
2019
28 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 12 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 95% of companies in human healthsector median 63.0% · 20,678 companies 97.7% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Comparable companies

These companies have the same main activity as Dr. Goedele Malfroid: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €609,000 and €747,000, founded between 2004 and 2007.

CompanyTotal assetsGross margin
Dr. Goedele Malfroid Laakdal€633,425€182,352
DR SAS GITTA Bornem€662,946€186,493
Dokters Bedert & van Doorn Kontich€608,856€192,832
DR. VAN MELLAERT C Antwerpen€641,052€190,887
DR WALTER SMOLDERS Schoten€734,238€194,563
Dr. I. MUYSHONDT Mechelen€747,201€189,281
Dr. Marthe Van den Berghe, reumatologie Lochristi€609,071€191,189
Full comparison

Documents

Annual accounts at the NBB

All 20 annual accounts

Articles and registers

Key facts about Dr. Goedele Malfroid

What is the company number of Dr. Goedele Malfroid?
The company number of Dr. Goedele Malfroid is 0885.242.784. The VAT number is the same number with BE in front: BE 0885.242.784.
Where is Dr. Goedele Malfroid based?
The registered office is at Kerkhofweg 8, 2430 Laakdal.Company details
What does Dr. Goedele Malfroid do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Goedele Malfroid?
The legal form of Dr. Goedele Malfroid is Private limited company (BV).
When was Dr. Goedele Malfroid founded?
Dr. Goedele Malfroid was founded on 27-11-2006.
Is Dr. Goedele Malfroid still active?
Yes, Dr. Goedele Malfroid is an active enterprise in the KBO register.
What is the turnover of Dr. Goedele Malfroid?
The turnover in financial year 2025 is ≈ €340,000. This figure is estimated from the gross margin of €182,352 and 43 comparable companies (NACE 86220). It probably lies between €290,000 and €450,000.Financials
Is Dr. Goedele Malfroid profitable?
In financial year 2025, Dr. Goedele Malfroid made a profit of €96,431.
Where can I find the annual accounts of Dr. Goedele Malfroid?
Dr. Goedele Malfroid filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Goedele Malfroid due?
Dr. Goedele Malfroid must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.